--Simple, Accurate, Affordable Solution for Pharmacogenomics Profiling to Identify Genetic Biomarkers Associated with Drug Response-- --Learn More About the Paragon Genomics CleanPlex ® NGS Panel at ...
Pharmacogenomics – testing a patient’s genetic makeup to guide safer, more effective medication choices and dosing – is not a new concept. But, like so many other clinical innovations, adoption has ...
Susanne B. Haga ([email protected]) is an associate professor of medicine at the Duke University School of Medicine, in Durham, North Carolina. Ariel Kantor is an undergraduate research assistant at ...
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies (Oxford Nanopore) today announced the launch of a new Pharmacogenomics (PGx) Beta Program to advance personalised medicine, combining ...
Genemarkers' PGx tests include drug-gene pairs that the Food and Drug Administration (FDA) and the Clinical Pharmacogenomics Implementation Consortium (CPIC) have recognized as having scientific ...
FREMONT, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Paragon Genomics, Inc., a global leader in target enrichment solutions for next-generation sequencing (NGS), today announced the launch of its new ...
KALAMAZOO, MA, UNITED STATES, December 6, 2022 / EINPresswire.com / -- Genemarkers, a leader in genomic research and pharmacogenomics, announced today that the New York State Department of Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results